Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

410 results about "Clostridium thermocellum" patented technology

Clostridium thermocellum is an anaerobic, thermophilic bacterium. C. thermocellum has garnered research interest due to its cellulolytic and ethanologenic abilities, being capable of directly converting a cellulosic substrate into ethanol by consolidated bioprocessing. This makes it useful in converting biomass into a usable energy source. The degradation of the cellulose is carried out in the bacterium by a large extracellular cellulase system called a cellulosome, which contains nearly 20 catalytic subunits. The cellulase system of the bacterium significantly differs from fungal cellulases due to its high activity on crystalline cellulose, being able to completely solubilize crystalline sources of cellulose, such as cotton. However, there are some shortfalls in applying the organism to practical applications due to it having low ethanol yield, at least partially due to branched fermentation pathways that produce acetate, formate, and lactate along with ethanol. There is also evidence of inhibition due to the presence of hydrogen and due to agitation. Some recent research has been directed to optimizing the ethanol-producing metabolic pathway in hopes of creating more efficient biomass conversion.

Affinity purified human polyclonal antibodies and methods of making and using them

InactiveUS20100150942A1Antibody ingredientsImmunoglobulinsBacteroidesAffinity purified antibody
The present invention describes a method for treating, removing or preventing a bacterial infection, which method comprises administering to a human suffering, suspected of suffering or at risk of suffering from Staphylococcus aureus (S. aureus) infection, a Streptococcus infection, Escherichia coli (E. coli) infection, Pseudomonas aeruginosa (P. aeruginosa) infection, Acinetobacter baumannii (A. baumannii) infection, Enterococcus faecium (E. faecium) infection and / or Clostridium difficile (C. difficile) infection, an effective amount of human polyclonal antibodies affinity purified from a human blood sample with an antigenic preparation comprising cellular and / or secreted antigen(s) from bacterial cells selected from S. aureus, a Streptococcus, E. coli, P. aeruginosa, A. baumannii, E. faecium, C. difficile or a combination thereof, and optionally, wherein said affinity purified human polyclonal antibodies are purified (e.g., as made more concentrated as compared to the starting or unpurified material) relative to the same human polyclonal antibodies in the unpurified or non-affinity-purified human blood sample, e.g., intravenous immunoglobulin (IVIG) sample, and / or also optionally, wherein said affinity purified human polyclonal antibodies are specific for the bacterial antigens used in the affinity purification, and / or further optionally wherein the affinity purified human polyclonal antibodies are substantially free of human antibodies that specifically bind to non-bacterial antigens in the human blood sample. Pharmaceutical compositions for treating bacterial infections, comprising an effective amount of human polyclonal antibodies affinity purified from a human blood sample with an antigenic preparation comprising cellular and / or secreted antigen(s) from S. aureus, Streptococcus, E. coli, P. aeruginosa, A. baumannii, E. faecium, C. difficile or a combination thereof, are also provided.
Owner:SCANTIBODIES LAB

Novel dihydrogen bond deep-eutectic solvent and method for pretreating rice straws through combination of solvent and sodium carbonate

The invention discloses a novel dihydrogen bond deep-eutectic solvent and a method for pretreating rice straws through combination of the solvent and sodium carbonate; straw hydrolysate after enzymolysis can be used for clostridium fermentation to synthesize bio-butanol. The deep-eutectic solvent provided by the invention is the novel dihydrogen bond deep-eutectic solvent which is synthesized by stirring choline chloride, formic acid and acetic acid at a molar ratio of 1:1:1 at the temperature of 30 DEG C; the solvent can be used for reducing the contents of lignin and hemicellulose in a lignocellulose raw material, so that the accessibility of cellulose in the lignocellulose raw material. The solvent and the sodium carbonate are combined to pretreat the rice straws, and enzyme hydrolysisis performed on the pretreated rice straws with cellulose, so as to obtain the hydrolysate containing 4.28g / L of total reducing sugar; the yield of glucose is 80%; in addition, the hydrolysate has noobvious inhibiting effect on the growth of microorganisms such as clostridium and the like, and the yield of butanol is 13.73g.L<-1>. The dihydrogen bond deep-eutectic solvent is an environment-friendly solvent which is simple in synthesis and convenient to use and has good application and development prospects in pretreatment of the lignocellulose raw material.
Owner:JIANGNAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products